期刊论文详细信息
NEUROPHARMACOLOGY 卷:131
Ginsenoside Rb1 confers neuroprotection via promotion of glutamate transporters in a mouse model of Parkinson's disease
Article
Zhang, Yun-Long1,2,3  Liu, Yan1,2,3  Kang, Xin-Pan1  Dou, Chun-Yan1  Zhuo, Ren-Gong1,3  Huang, Shu-Qiong1  Peng, Li1  Wen, Lei1,2 
[1] Xiamen Univ, Dept Tradit Chinese Med, Coll Med, Xiamen 361102, Peoples R China
[2] Xiamen Univ, Fujian Prov Key Lab Neurodegenerat Dis & Aging Re, Coll Med, Inst Neurosci, Xiamen 361102, Peoples R China
[3] Xiamen Univ, Shenzhen Res Inst, Shenzhen 518000, Peoples R China
关键词: Parkinson's disease;    Ginsenoside Rb1;    Glutamatergic transmission;    Glutamate transporters;   
DOI  :  10.1016/j.neuropharm.2017.12.012
来源: Elsevier
PDF
【 摘 要 】

Ginsenoside Rb1 has been demonstrated to protect dopaminergic (DA) neurons from death in vitro. However, the neuroprotective effects and underlying mechanism of Rb1 in treating Parkinson's disease (PD) remain uncharacterized. In this study, we explored the effects of Rb1 on the movement disorder and the underlying mechanisms based on the glutamatergic transmission and excitotoxicity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of PD. Here, for the first time, we report that Rb1 treatment ameliorates motor deficits, prevents DA neuron death, and suppresses alpha-synuclein expression and astrogliosis in the MPTP mouse model of PD. Rb1 attenuates glutamate excitotoxicity by upregulating glutamate transporter expression and function, and modulating the nigrostriatal and cortico-nigral glutamatergic transmission pathways. Our results demonstrate that Rb1 increases glutamate transporter expression via nuclear translocation of nuclear factor-kappa B, regulates glutamate receptor expression and promotes synaptic protein expression. These results indicate that Rb1 suppresses glutamate excitotoxicity and modulates synaptic transmission to improve the impairments in motor functions of the MPTP model of PD, suggesting that Rb1 may serve as a potential therapeutic agent for PD. (C) 2017 The Authors. Published by Elsevier Ltd.

【 授权许可】

Free   

【 预 览 】
附件列表
Files Size Format View
10_1016_j_neuropharm_2017_12_012.pdf 6324KB PDF download
  文献评价指标  
  下载次数:0次 浏览次数:0次